
    
      This is an observational, registry study to assess patient survival and clinical outcomes of
      the RenovoCath™ RC120 catheter when used to deliver chemotherapeutic agents to pancreatic
      tumors. Blood samples will be drawn in a subset of patients to assess the systemic
      concentration of the chemotherapeutic agent.

      The RenovoCath™ RC120 Catheter is an endovascular multi-lumen, two-handled catheter designed
      to isolate variable segments of arteries supplying the target organ using two slideable,
      compliant balloons. Upon inflation of the proximal occlusion balloon and the distal occlusion
      balloon, the catheter may isolate the selected site to specifically deliver radiopaque and
      therapeutic agents including, but not limited to chemotherapeutic drugs.
    
  